Search Results Search Sort by RelevanceMost Recent Case and Commentary Jul 2007 Avoiding Disincentives to Treat in Designing Pay-for-Performance Measures Meredith B. Rosenthal, PhD To be a useful tool for assessing quality of physician care, pay-for-performance must be designed to include process measures and to not penalize physicians for treating patients with difficult-to-manage conditions. Virtual Mentor. 2007;9(7):483-486. doi: 10.1001/virtualmentor.2007.9.7.ccas2-0707. Case and Commentary Jul 2024 When Are “Paraphernalia” Critical Medical Supplies? Adriane M. dela Cruz, MD, PhD, Donald Egan, MD, MPH, Sarah E. Baker, MD, MA, and John Z. Sadler, MD Evidence of harm reduction interventions’ morbidity and mortality benefits is abundant and of high quality. AMA J Ethics. 2024;26(7):E527-533. doi: 10.1001/amajethics.2024.527. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Page 5 Current page 6
Case and Commentary Jul 2007 Avoiding Disincentives to Treat in Designing Pay-for-Performance Measures Meredith B. Rosenthal, PhD To be a useful tool for assessing quality of physician care, pay-for-performance must be designed to include process measures and to not penalize physicians for treating patients with difficult-to-manage conditions. Virtual Mentor. 2007;9(7):483-486. doi: 10.1001/virtualmentor.2007.9.7.ccas2-0707.
Case and Commentary Jul 2024 When Are “Paraphernalia” Critical Medical Supplies? Adriane M. dela Cruz, MD, PhD, Donald Egan, MD, MPH, Sarah E. Baker, MD, MA, and John Z. Sadler, MD Evidence of harm reduction interventions’ morbidity and mortality benefits is abundant and of high quality. AMA J Ethics. 2024;26(7):E527-533. doi: 10.1001/amajethics.2024.527.